Pharmaceutical Technology

MARCH 1, 2023

After almost seven years of research and advancement post-initial approval, ASO therapies now represent over 50% of all RNA-based therapeutics in clinical development, according to GlobalData’s pipeline product database, and may emerge as improved and highly disruptive next-generation RNA therapies.

RNA 147

RNA Vaccination Vaccine Genetics 147

XTalks

MAY 19, 2023

Clinical trials play a vital role in advancing patient treatment and medical care. This article delves into ten trends and statistics in the world of clinical trials for 2023. And don’t forget to explore the upcoming webinars about clinical trials on Xtalks to see what piques your curiosity about the latest clinical trial solutions.

Clinical Trials 97

Clinical Trials Clinical Trials Trials Clinical Research 97

The Pharma Data

SEPTEMBER 16, 2020

New and updated data from across our broad cancer portfolio including phase III results in breast, lung and prostate cancers. New integrated analyses from our tumour agnostic Rozlytrek ® (entrectinib) clinical development programme. Sign up here for the session on Saturday, 19 September, 16:00-16:30 CEST.

HR 52

HR Medicine Hormones Trials 52

Pfizer

NOVEMBER 2, 2022

Pfizer and BioNTech Initiate Phase 1 Study of Single Dose mRNA-Based Combination Vaccine Candidate for Influenza and COVID-19. Pfizer and BioNTech Initiate Phase 1 Study of Single Dose mRNA-Based Combination Vaccine Candidate for Influenza and COVID-19. About the Phase 1 Study . Wed, 11/02/2022 - 15:44.

Vaccination 85

Vaccination Vaccine Clinical Trials Clinical Trials 85

The Pharma Data

AUGUST 22, 2021

Two formulations were approved, a tablet and a new oral solution (weight-based dosing). We are proud to make these new options available in the EU as Pfizer continues to advance the science and understanding of medicines like XELJANZ, which has been studied in more than 50 trials across clinical programs worldwide.”.

Marketing 52

Marketing Clinical Trials Clinical Trials Development 52